<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi>, an anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapeutic agent used for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, commonly causes gastrointestinal side-effects such as <z:hpo ids='HP_0002019'>constipation</z:hpo>, diarrhoea, <z:hpo ids='HP_0002018'>nausea</z:hpo>, and <z:hpo ids='HP_0002013'>vomiting</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Damage to enteric neurons may underlie some of these gastrointestinal side-effects, as the enteric <z:mp ids='MP_0008912'>nervous</z:mp> system (ENS) controls functions of the bowel </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> and changes to the structure and immunoreactivity of myenteric neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (nNOS) neurons were examined in colonic segments from mice following exposure to <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> ex vivo and following repeated intraperitoneal injections of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> over 3 weeks in vivo, using immunohistochemistry and confocal microscopy </plain></SENT>
<SENT sid="3" pm="."><plain>Significant morphological alterations and increases in the proportion of NOS-immunoreactive (IR) neurons were associated with both short-term <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> exposure and long-term <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> administration, confirming that <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> causes changes to the myenteric neurons </plain></SENT>
<SENT sid="4" pm="."><plain>Long-term <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> administration induced substantial <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> that was correlated with a reduction in both the frequency and propagation speed of colonic migrating motor complexes (CMMCs) in vitro </plain></SENT>
<SENT sid="5" pm="."><plain>Similar changes probably produce some symptoms experienced by patients undergoing <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> treatment </plain></SENT>
</text></document>